Gregory Wade

Dr. Gregory Wade has served as EXUMA Biotech’s Chief Business Officer since January 2022. Dr. Wade has over 20 years-experience in the biotechnology industry. Most recently, he held the position Managing Director, Capital Markets Advisory, and Co-Lead of the West Coast Region for Danforth Advisors. From 2015-2021, Dr. Wade was a Managing Director in BTIG’s Healthcare Investment Banking Group. Prior to his role with BTIG, Dr. Wade served as Head of Business Development at Pharmacyclics, a role he held following 16 years of work in healthcare equity research at Pacific Growth Equities and its successor, Wedbush PacGrow. Dr. Wade earned his undergraduate degree in biophysics, and his Ph.D. in physiology, from Western University in London, Canada.